Carr Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.02M Buy
4,340
+719
+20% +$848K 1.12% 19
2026
Q2
$4.34M Sell
3,621
-103
-3% -$105K 1% 21
2026
Q1
$3.42M Buy
3,724
+19
+0.5% +$19.3K 0.9% 22
2025
Q4
$3.98M Sell
3,705
-294
-7% -$281K 1.06% 20
2025
Q3
$3.05M Buy
3,999
+655
+20% +$487K 0.84% 23
2025
Q2
$2.61M Buy
3,344
+75
+2% +$58.3K 0.77% 26
2025
Q1
$2.7M Sell
3,269
-380
-10% -$316K 0.88% 24
2024
Q4
$2.82M Sell
3,649
-11
-0.3% -$9.11K 0.87% 25
2024
Q3
$3.24M Sell
3,660
-435
-11% -$391K 0.95% 23
2024
Q2
$3.71M Buy
4,095
+27
+0.7% +$21.6K 1.18% 18
2024
Q1
$3.16M Sell
4,068
-318
-7% -$226K 1.05% 19
2023
Q4
$2.56M Hold
4,386
– – 0.95% 21
2023
Q3
$2.49M Sell
4,386
-84
-2% -$43.3K 0.99% 22
2023
Q2
$2.1M Hold
4,470
– – 0.84% 23
2023
Q1
$1.54M Sell
4,470
-300
-6% -$101K 0.68% 28
2022
Q4
$1.75M Buy
+4,770
New +$1.69M 0.92% 25

Other funds holding LLY

Carr Financial Group's LLY Position: Q3 2026 in Review

Carr Financial Group increased its Eli Lilly (LLY) stake by 20% in Q3 2026, buying an estimated $848K and bringing the position to 4,340 shares worth $5.02M. The position accounts for 1.12% of the portfolio, ranked #19.

Carr Financial Group first reported a position in LLY in Q4 2022 and has held it in 16 quarters since. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Carr Financial Group held 4,340 shares of Eli Lilly worth $5.02M as of Q3 2026.
  • Carr Financial Group bought 719 Eli Lilly shares in Q3 2026, an estimated $848K.
  • Eli Lilly made up 1.12% of Carr Financial Group's portfolio in Q3 2026, its #19 holding.
  • Carr Financial Group first reported a position in Eli Lilly in Q4 2022 and has held it in 16 quarters since.
  • 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Carr Financial Group's 13F filing for Q3 2026, filed 10 Nov 2026.